The surgical referral policies for patients with trigger finger, ganglion removal and Dupuytren’s disease were collected for all Clinical Commissioning Groups in England. The aim was to assess whether there was variation in the policies across England, resulting in inequality in patients’ access to surgery. Data were collected between October 2018 and January 2019 and compared with national guidelines. Analysis of the results showed that for all three conditions, surgical commissioning policies varied depending on the locality. The results also show that despite the existence of national guidelines, they are not implemented. This has the potential to lead to variation in surgical referral and access to services for patients in different localities in England.
BainbridgeCDahlinLBSzczypaPPCappelleriJCGuérinDGerberRA. Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012, 3: 31–41.
2.
BaltzerHBinhammerPA. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies. Bone Joint J. 2013, 95: 1094–100.
3.
BinhammerP. Comparative outcomes of Dupuytren disease treatment. Hand Clin. 2018, 34: 377–86.
4.
BlumbergNArbelRDekelS. Percutaneous release of trigger digits. J Hand Surg Br. 2001, 26: 256–7.
5.
BrazzelliMCruickshankMTassieE, et al.Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Health Technol Assess. 2015, 19: 1–202.
ChenNCShauverMJChungKC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg Am. 2011, 36: 1826–34.
8.
HeadLGencarelliJRAllenMBoydKU. Wrist ganglion treatment: systematic review and meta-analysis. J Hand Surg Am. 2015, 40: 546–53.
9.
KhanPSHayatH. Surgical excision versus aspiration combined with intralesional triamcinolone acetonide injection plus wrist immobilization therapy in the treatment of dorsal wrist ganglion; a randomized controlled trial. J Hand Microsurg. 2011, 3: 55–7.
10.
LangerDMaeirAMichailevichMApplebaumYLuriaS. Using the international classification of functioning to examine the impact of trigger finger. Disabil Rehabil. 2016, 38: 2530–7.
11.
LidderSRanawatVAhrensP. Surgical excision of wrist ganglia; literature review and nine-year retrospective study of recurrence and patient satisfaction. Orthop Rev (Pavia). 2009, 30: e5.
12.
LimMHLimKKRasheedMZNarayananSBeng-Hoi TanA. Outcome of open trigger digit release. J Hand Surg Eur. 2007, 32: 457–9.
13.
LutherGAMurthyPBlazarPE. Cost of immediate surgery versus non-operative treatment for trigger finger in diabetic patients. J Hand Surg Am. 2016, 41: 1056–63.
14.
MoorhouseAGiddinsG. National variation between clinical commissioning groups in referral criteria for primary total hip replacement surgery. Ann R Coll Surg Engl. 2018, 100: 443–5.
RyanDShawAGrahamSMasonW. Variation in CCG policies for the treatment of carpal tunnel syndrome. RCS Bulletin. 2017, 99: 28–31.
18.
SmithHKhanMHarrisonS, et al.Regional variations in the referral criteria for the surgical treatment of varicose veins. RCS Bulletin. 2015, 97: 70–3.
19.
SoreideEMuradMHDenbeighJM, et al.Treatment of Dupuytren's contracture: a systematic review. Bone Joint J. 2018, 100: 1138–45.
20.
StirlingPJenkinsPJClementNDDuckworthADMcEachanJE. The net promoter scores with friends and family test after four hand surgery procedures. J Hand Surg Eur. 2019, 44: 290–5.
21.
WangJZhaoJGLiangCC. Percutaneous release, open surgery, or corticosteroid injection, which is the best treatment method for trigger digits?. Clin Orthop Relat Res. 2013, 471: 1879–86.
22.
ZylukAJagielskiG. Percutaneous A1 pulley release vs steroid injection for trigger digit: the results of a prospective, randomized trial. J Hand Surg Eur. 2011, 36: 53–6.
